REG-Convatec Group PLC Convatec Group PLC: Total Voting Rights

ConvaTecAnnouncement

29/09/2023 19:45

============

   Convatec Group PLC (CTEC)
   Convatec Group PLC: Total Voting Rights

   29-Sep-2023 / 19:33 GMT/BST

   ══════════════════════════════════════════════════════════════════════════

   29 September 2023

                               Convatec Group Plc
                         ("Convatec" or "the Company")

                              Total Voting Rights

   The following notification  is made  in accordance with  the UK  Financial
   Conduct Authority's  Disclosure  and Transparency  Rule  5.6.1. As  at  29
   September 2023, the Company's issued capital with voting rights  consisted
   of 2,049,789,559 ordinary shares of 10p each (“Shares”). The Company  does
   not hold any Shares in Treasury at the date of this disclosure.

   The above  figure  (2,049,789,559) can  be  used by  shareholders  as  the
   denominator for  the  calculations  by  which to  determine  if  they  are
   required to notify their  interest in, or a  change to, their interest  in
   the Company  under the  UK Financial  Conduct Authority's  Disclosure  and
   Transparency Rules. 

    

   Enquiries

    

   Grace McCalla, Senior Assistant Company
   Secretary                                            +44(0)7575353388

    

   Cosec@convatec.com 

    

   Convatec Group Plc’s LEI code is 213800LS272L4FIDOH92

    

   About Convatec

    

   Pioneering trusted  medical  solutions  to improve  the  lives  we  touch:
   Convatec is a global medical products and technologies company, focused on
   solutions for the management of chronic conditions, with leading positions
   in advanced wound care,  ostomy care, continence  care and infusion  care.
   With around 10,000  colleagues, we  provide our products  and services  in
   almost 100  countries, united  by  a promise  to  be forever  caring.  Our
   solutions provide  a  range of  benefits,  from infection  prevention  and
   protection of at-risk skin, to improved patient outcomes and reduced  care
   costs. Group  revenues in  2022 were  over $2  billion. The  company is  a
   constituent of  the  FTSE 100  Index  (LSE:  CTEC). To  learn  more  about
   Convatec, please visit  1 www.convatecgroup.com.

    

   ══════════════════════════════════════════════════════════════════════════

   Dissemination of a Regulatory Announcement, transmitted by EQS Group.
   The issuer is solely responsible for the content of this announcement.

   ══════════════════════════════════════════════════════════════════════════

   ISIN:          GB00BD3VFW73
   Category Code: TVR
   TIDM:          CTEC
   LEI Code:      213800LS272L4FIDOH92
   Sequence No.:  275017
   EQS News ID:   1738565


    
   End of Announcement EQS News Service

   ══════════════════════════════════════════════════════════════════════════

    2 fncls.ssp?fn=show_t_gif&application_id=1738565&application_name=news&site_id=refinitiv2

References

   Visible links
   1. https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=26f8de477e9a42123589f91471356e0b&application_id=1738565&site_id=refinitiv2&application_name=news


============